These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6288991)

  • 1. Cerebrospinal fluid markers in African Burkitt's lymphoma with central nervous system involvement.
    Wallen WC; Biggar RJ; Levine PH; Neequaye J; Nkrumah FK
    J Natl Cancer Inst; 1982 Oct; 69(4):787-92. PubMed ID: 6288991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-immune complexes in postmortem kidneys from African patients with Burkitt's lymphoma and American patients with and without lymphoma.
    Sutherland JC; Olweny CL; Levine PH; Mardiney MR
    J Natl Cancer Inst; 1978 May; 60(5):941-6. PubMed ID: 205665
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma.
    Oldstone MB; Theofilopoulos AN; Gunvén P; Klein G
    Intervirology; 1974; 4(5):292-302. PubMed ID: 4377147
    [No Abstract]   [Full Text] [Related]  

  • 4. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of immunological findings in Burkitt's lymphoma. (Epstein-Barr virus-associated antibodies/BCG treatment.
    Gunvén P
    Hamatol Bluttransfus; 1974; 14():129-32. PubMed ID: 4375070
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
    Morrow RH; Sever JL; Henderson BE
    Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
    [No Abstract]   [Full Text] [Related]  

  • 7. Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas.
    Besson C; Amiel C; Le-Pendeven C; Plancoulaine S; Bonnardel C; Ranque B; Abbed K; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Bresson JL; Nicolas JC; Gessain A; Dethe G; Abel L
    J Infect Dis; 2009 Apr; 199(8):1121-7. PubMed ID: 19284285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligoclonal IgG in CSF of patients with African Burkitt's lymphoma.
    Wallen WC; Biggar RJ; Levine PH; Iivanainen MV
    Arch Neurol; 1983 Jan; 40(1):11-3. PubMed ID: 6848080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very late relapses in patients with Burkitt's lymphoma: clinical and serologic studies.
    Biggar RJ; Nkrumah FK; Henle W; Levine PH
    J Natl Cancer Inst; 1981 Mar; 66(3):439-44. PubMed ID: 6259398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
    Gunven P
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
    [No Abstract]   [Full Text] [Related]  

  • 12. EVB-associated immune complexes and recurrent Burkitt's lymphoma.
    Gunven P; Klein G; Rosen A; Mukojima T
    IARC Sci Publ (1971); 1978; (24 Pt 2):875-82. PubMed ID: 221409
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-Barr virus and rheumatoid arthritis: are rheumatoid arthritis associated nuclear antigen and Epstein-Barr virus nuclear antigen different?
    Cohen JH; Lenoir GM
    Biomed Pharmacother; 1982; 36(5):246-9. PubMed ID: 6301567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese Burkitt's lymphoma: clinicopathological review of 14 cases.
    Miyoshi I
    Jpn J Clin Oncol; 1983 Sep; 13(3):489-96. PubMed ID: 6315992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological evidence for active Epstein-Barr virus infection in multifocal choroiditis.
    Bhende PS; Biswas J; Madhavan HN
    Indian J Pathol Microbiol; 1997 Apr; 40(2):129-31. PubMed ID: 9257497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Epstein-Barr virus-negative B lymphoma cell line (THP-2) from a Burkitt's lymphoma of a Japanese patient.
    Tsuchiya S; Yamaguchi Y; Kobayashi Y; Minegishi M; Imaizumi M; Suzuki H; Konno T; Tada K
    Tohoku J Exp Med; 1983 Aug; 140(4):429-34. PubMed ID: 6314596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen.
    Dölken G; Boldt C; Lange W; Weitzmann U; Löhr GW; Rosén A
    Cancer Detect Prev; 1983; 6(1-2):287-92. PubMed ID: 6309387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The isolation of the antibody moieties of immune complexes from serum by the pepsin digestion of conglutinin-anti-conglutinin complexes.
    Lachmann PJ; Macanovic M; Harkiss GD; Oldroyd RG; Habicht J
    Clin Exp Immunol; 1981 Nov; 46(2):250-8. PubMed ID: 6279342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.